MYLIFE
LIVE

Serial Number

86366332

Owner

YPSOMED AG

Attorney

Joel D. Leviton

Filing Date

Aug 14, 2014

Add to watchlist:

No watchlists yet
View on USPTO

MYLIFE Trademark

Serial Number: 86366332 • Registration: 6150285

MYLIFE is a trademark filed by YPSOMED AG on August 14, 2014. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

YPSOMED AG (37 trademarks)

BRUNNMATTSTRASSE 6
BURGDORF CH-3400 , CH

Entity Type: 03

TecPharma Licensing AG (42 trademarks)

Brunnmattstrasse 6
3401 Burgdorf CH-3401 , CH

Entity Type: 99

MYLIFE DIABETES CARE AG

LYSSACHSTRASSE 40
BURGDORF 3400 , CH

Entity Type: 03

Trademark Details

Filing Date

August 14, 2014

Registration Date

September 15, 2020

Published for Opposition

June 30, 2020

Goods & Services

Media for digital transmission, storage, and processing of medical data in relation with continuous subcutaneous insulin infusion therapy and data provided by medical instruments and devices in the nature of insulin pumps, blood glucose meters, and patch pumps for continuous subcutaneous insulin infusion, namely, smart phones, smart tablets, smart watches, and smart bracelets; Software for depicting and analyzing data namely blood glucose values, blood glucose trends versus time, blood glucose target value, current bolus values, bolus history, insulin on board or unused insulin, carbohydrate values, carbohydrate factor, insulin sensitivity factor, duration of insulin action, carbohydrate to insulin factor, calculation and display of meal bolus, calculation and display of correction bolus, calculation and display of insulin stacking, display of bolus suggestion, current basal rate, basal rate profile, basal rate history provided by medical instruments and devices for continuous subcutaneous insulin infusion, namely, insulin pumps, blood glucose meters, and patch pumps; Downloadable databases featuring blood glucose values; Software for managing data pertaining to infused insulin and infused insulin history of patients using insulin pumps; Software for data management of patients using insulin pumps; Remote control devices, namely, remote controls for medical instruments and devices in the nature of insulin pumps, blood glucose meters, and patch pumps that provide continuous subcutaneous insulin infusion

Providing access to information for user of medical instruments and devices for self-medication, particularly diabetes therapies, by means of a global computer information network; providing online information forums, chatrooms, chat lines, and chat forums for the transmission of messages and information between computer users with regard to medical instruments and devices for self-medication, particularly, diabetes therapies

Media for digital transmission, storage, and processing of medical data in relation with continuous subcutaneous insulin infusion therapy and of data provided by medical instruments and devices in the nature of insulin pumps, blood glucose meters, and patch pumps for continuous subcutaneous insulin infusion, namely, handheld, body-worn and implanted devices, personal diabetes managers devices, and smart medical devices in the nature of wireless handheld devices; all of the foregoing that allow users to control insulin pumps, blood glucose meters and patch pumps for medical purposes; Medical instruments and devices, namely, insulin pumps sold empty, blood glucose meters, and patch pumps sold empty, for continuous subcutaneous insulin infusion

Providing online computer databases featuring blood glucose values, blood glucose trends versus time, blood glucose target value, current bolus values, bolus history, insulin on board or unused insulin, carbohydrate values, carbohydrate factor, insulin sensitivity factor, duration of insulin action, carbohydrate to insulin factor, calculation and display of meal bolus, calculation and display of correction bolus, calculation and display of insulin stacking, display of bolus suggestion, current basal rate, basal rate profile, basal rate history for data management of patients using insulin pumps

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 6, 2026 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 15, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 22, 2021 ASGN
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 23, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 26, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 26, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 26, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 1, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 1, 2019 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2019 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 16, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 16, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 16, 2019 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 25, 2019 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 22, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 22, 2018 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 21, 2018 TCCA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 22, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 22, 2017 GNSL
SUSPENSION LETTER WRITTEN
Sep 22, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2017 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 20, 2017 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 17, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 17, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 17, 2017 CNSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 16, 2017 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 14, 2016 RCSC
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2016 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 14, 2016 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 14, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 14, 2015 GNSL
SUSPENSION LETTER WRITTEN
Jul 14, 2015 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 22, 2015 CRFA
ASSIGNED TO LIE
Jun 15, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 10, 2014 GNRN
NON-FINAL ACTION E-MAILED
Dec 10, 2014 GNRT
NON-FINAL ACTION WRITTEN
Dec 10, 2014 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2014 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Aug 23, 2014 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2014 NWOS
NEW APPLICATION ENTERED
Aug 18, 2014 NWAP